Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip

doi:10.1161/CIRCULATIONAHA.111.055079

Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

Leif Friberg, Mårten Rosenqvist, Gregory Y H Lip

Cardiovascular Sciences

Research output: Contribution to journal › Article › peer-review

348 Citations (Scopus)

Abstract

Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.

Original language	English
Pages (from-to)	2298-2307
Number of pages	10
Journal	Circulation
Volume	125
Issue number	19
Early online date	18 Apr 2012
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.111.055079
Publication status	Published - 18 Apr 2012

Access to Document

10.1161/CIRCULATIONAHA.111.055079Licence: None: All rights reserved

Cite this

@article{5da72be9b35c42909fa18f814261b896,

title = "Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study",

abstract = "Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.",

author = "Leif Friberg and M{\aa}rten Rosenqvist and Lip, {Gregory Y H}",

year = "2012",

month = apr,

day = "18",

doi = "10.1161/CIRCULATIONAHA.111.055079",

language = "English",

volume = "125",

pages = "2298--2307",

journal = "Circulation",

issn = "0009-7322",

publisher = "American Heart Association",

number = "19",

}

TY - JOUR

T1 - Net clinical benefit of warfarin in patients with atrial fibrillation

T2 - a report from the Swedish atrial fibrillation cohort study

AU - Friberg, Leif

AU - Rosenqvist, Mårten

AU - Lip, Gregory Y H

PY - 2012/4/18

Y1 - 2012/4/18

N2 - Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.

AB - Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.

U2 - 10.1161/CIRCULATIONAHA.111.055079

DO - 10.1161/CIRCULATIONAHA.111.055079

M3 - Article

C2 - 22514252

SN - 0009-7322

VL - 125

SP - 2298

EP - 2307

JO - Circulation

JF - Circulation

IS - 19

ER -

Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study

Abstract

Access to Document

Fingerprint

Cite this